Prevencio

Kirkland, United States Founded: 2006 • Age: 20 yrs
Protein-based diagnostics and prognostics for cardiovascular diseases are developed.
Annual revenue - Latest available
Total funding $5.7M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About Prevencio

Prevencio is a company based in Kirkland (United States) founded in 2006. Prevencio has raised $5.68 million across 2 funding rounds. Prevencio offers products and services including HART Tests. Prevencio operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.

  • Headquarter Kirkland, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Prevencio Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $5.68 M (USD)

    in 2 rounds

  • Latest Funding Round
    $675 K (USD), Series B

    Apr 07, 2016

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Prevencio

Prevencio offers a comprehensive portfolio of products and services, including HART Tests.

Product name locked
Category locked
Primary

AI-powered blood tests for detecting heart disease and predicting risks.

People of Prevencio

Headcount 1-10
Employee Profiles 8
Board Members and Advisors 3
Employee Profiles
People
Rhonda F. Rhyne
CEO, President & Director
People
Caitlyn Dzhafarov
VP, Quality & Regulatory

Unlock access to complete

Funding Insights of Prevencio

Prevencio has successfully raised a total of $5.68M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $675 thousand completed in April 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Prevencio

Investments
Premium access

Investment portfolio details for Prevencio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Prevencio

Premium access

Detailed financials for Prevencio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Prevencio Comparisons

Prevencio Primary company
Description
Protein-based diagnostics and prognostics for cardiovascular...
Location
Kirkland, United States
Founded Year
2006
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Prevencio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Prevencio

Prevencio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genetic and clinical data are integrated for precision cardiac medicines.
Locked Locked Locked
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
Locked Locked Locked
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
Locked Locked Locked
Interventional cardiology devices are developed and marketed globally.
Locked Locked Locked
Cardiac imaging systems are manufactured using advanced molecular technologies.
Locked Locked Locked
Handheld immunodiagnostic devices for cardiac vascular diseases are developed.
Premium access

Detailed competitors of Prevencio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Prevencio

Premium access

Complete news archive for Prevencio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prevencio

Prevencio was founded in 2006 and raised its 1st funding round 9 years after it was founded.

Prevencio is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.

Prevencio is a funded company, having raised a total of $5.68M across 2 funding rounds to date.

Founded in 2006 in Kirkland, United States, Prevencio operates in the biotechnology sector focused on cardiovascular health. Protein-based diagnostics and prognostic solutions are developed for diseases such as coronary artery disease. The HART assay, utilizing proteomics, is employed to diagnose coronary artery disease. Risks of myocardial infarction, stroke, or cardiovascular death within one year are assessed for diagnosed patients through protein signatures.

Prevencio's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.

Prevencio offers HART Tests.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available